Optimal control of mixed immunotherapy and chemotherapy of tumours with discrete delay-Reference-Cited by-同舟云学术

Optimal control of mixed immunotherapy and chemotherapy of tumours with discrete delay

Published:2015-12-16 Issue:3 Volume:5 Page:872-892
ISSN:2195-268X
Container-title:International Journal of Dynamics and Control
language:en
Short-container-title:Int. J. Dynam. Control

Author:

Krishnapriya P.,Pitchaimani M.

Publisher

Springer Science and Business Media LLC

Subject

Electrical and Electronic Engineering,Control and Optimization,Mechanical Engineering,Modelling and Simulation,Civil and Structural Engineering,Control and Systems Engineering

Link

http://link.springer.com/content/pdf/10.1007/s40435-015-0221-y.pdf

Reference59 articles.

1. Adam JA, Bellomo N (eds) (1997) A survey of models for tumourimmune system dynamics. Birkhäuser, Boston

2. Norris ES, King JR, Byrne HM (2006) Modelling the response of spatially structured tumours to chemotherapy: drugkinetics. Math Comput Model 43:820–837

3. Araujo R, McElwain D (2004) A history of the study of solid tumour growth: the contribution of mathematical modeling. Bull Math Biol 66:1039–1091

4. Bellomo N, Li N, Maini P (2008) On the foundations of cancer modeling: selected topics, speculations, and perspectives. Math Models Methods Appl Sci 18:593–646

5. Bellomo N, Preziosi L (2000) Modelling and mathematical problems related to tumour evolution and its reactions with immune system. Math Comput Model 32:413–452

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy;European Journal of Control;2022-07

2. Modified HIV-1 infection model with delay in saturated CTL immune response;Communications in Mathematical Biology and Neuroscience;2022

3. Exploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission;PLOS ONE;2018-09-05

4. Optimal control of tumor–immune system interaction with treatment;AIP Conference Proceedings;2018

5. Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control;Journal of Biological Dynamics;2017-01